2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure.
Chung MK, Patton KK, Lau CP, Dal Forno ARJ, Al-Khatib SM, Arora V, Birgersdotter-Green UM, Cha YM, Chung EH, Cronin EM, Curtis AB, Cygankiewicz I, Dandamudi G, Dubin AM, Ensch DP, Glotzer TV, Gold MR, Goldberger ZD, Gopinathannair R, Gorodeski EZ, Gutierrez A, Guzman JC, Huang W, Imrey PB, Indik JH, Karim S, Karpawich PP, Khaykin Y, Kiehl EL, Kron J, Kutyifa V, Link MS, Marine JE, Mullens W, Park SJ, Parkash R, Patete MF, Pathak RK, Perona CA, Rickard J, Schoenfeld MH, Seow SC, Shen WK, Shoda M, Singh JP, Slotwiner DJ, Sridhar ARM, Srivatsa UN, Stecker EC, Tanawuttiwat T, Tang WHW, Tapias CA, Tracy CM, Upadhyay GA, Varma N, Vernooy K, Vijayaraman P, Worsnick SA, Zareba W, Zeitler EP.
Heart Rhythm. 2023 Sep;20(9):e17-e91. doi: 10.1016/j.hrthm.2023.03.1538. Epub 2023 May 20.
Management of Heart Failure Patient with CKD.
Banerjee D, Rosano G, Herzog CA.
Clin J Am Soc Nephrol. 2021 Jul;16(7):1131-1139. doi: 10.2215/CJN.14180920. Epub 2021 Jan 25.
EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS).
Burri H, Jastrzebski M, Cano Ó, Čurila K, de Pooter J, Huang W, Israel C, Joza J, Romero J, Vernooy K, Vijayaraman P, Whinnett Z, Zanon F.
Europace. 2023 Apr 15;25(4):1208-1236. doi: 10.1093/europace/euad043.
Nanostim-leadless pacemaker.
Sperzel J, Hamm C, Hain A.
Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):327-333. doi: 10.1007/s00399-018-0598-3. Epub 2018 Oct 19.
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Mark Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S.
Heart Rhythm. 2016 Feb;13(2):e50-86. doi: 10.1016/j.hrthm.2015.11.018. Epub 2015 Dec 1.
Truncal Plane Blocks for Implantation of Cardiac Resynchronization Devices: A Systematic Review.
Bridges H, Tran D, Lopez RA, Ericksen AM.
AANA J. 2024 Feb;92(1):63-71.
Coronary Sinus Lead Positioning.
Roka A, Borgquist R, Singh J.
Heart Fail Clin. 2017 Jan;13(1):79-91. doi: 10.1016/j.hfc.2016.07.007.
Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial.
Fujiki S, Iijima K, Nakagawa Y, Takahashi K, Okabe M, Kusano K, Owada S, Kondo Y, Tsujita K, Shimizu W, Tomita H, Watanabe M, Shoda M, Watanabe M, Tokano T, Murohara T, Kaneshiro T, Kato T, Hayashi H, Maemura K, Niwano S, Umemoto T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Minamino T; EMPA ICD investigators.
Cardiovasc Diabetol. 2024 Jun 28;23(1):224. doi: 10.1186/s12933-024-02309-9.
Cardiac Resynchronization Therapy for Non-Left Bundle Branch Block: Time for Change?
Qin D, Singh JP.
JACC Clin Electrophysiol. 2024 Jan;10(1):27-30. doi: 10.1016/j.jacep.2023.11.010.
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure.
Singh JP, Rinaldi CA, Sanders P, Kubo SH, James S, Niazi IK, Betts T, Butter C, Okabe T, Cunnane R, Aziz E, Biffi M, Zaidi A, Alison J, Defaye P, Aurrichio A, Gold MR, Lindenfeld J, Rogers T, Walsh MN; SOLVE-CRT Investigators.
JAMA Cardiol. 2024 Oct 1;9(10):871-879. doi: 10.1001/jamacardio.2024.2050.
